University of Kansas Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Determining the recommended dose of pacritinib: Results from the PAC203 dose-finding trial in advanced myelofibrosis

    Blood Advances, Vol. 4, Núm. 22, pp. 5825-5835